{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:57:19Z","timestamp":1787623039388,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ucl.2025.07.007","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:02:00Z","timestamp":1755615720000},"page":"559-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Balloons in Benign Prostatic Hyperplasia"],"prefix":"10.1016","volume":"52","author":[{"given":"Alexis E.","family":"Te","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ucl.2025.07.007_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1148\/radiology.157.1.2412259","article-title":"Balloon dilatation of the prostatic urethra. Work in progress","volume":"157","author":"Quinn","year":"1985","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.007_bib2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1148\/radiology.163.3.2437611","article-title":"Benign prostatic hypertrophy: retrograde transurethral dilation of the prostatic urethra in humans. Work in progress","volume":"163","author":"Castaneda","year":"1987","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.007_bib3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1464-410X.1989.tb05321.x","article-title":"Bladder outflow tract obstruction and urinary retention from benign prostatic hypertrophy treated by balloon dilatation","volume":"64","author":"Gill","year":"1989","journal-title":"Br J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.007_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0094-0143(21)01600-1","article-title":"Balloon dilatation of the prostate for treatment of benign hyperplasia","volume":"15","author":"Reddy","year":"1988","journal-title":"Urol Clin North Am"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.007_bib5","first-page":"499","article-title":"Balloon dilatation of the prostate","volume":"24","author":"Dowd","year":"1997","journal-title":"Urol Clin North Am"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.007_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0022-5347(17)37331-7","article-title":"Randomized double-blind study comparing the effectiveness of balloon dilation of the prostate and cystoscopy for the treatment of symptomatic benign prostatic hyperplasia","volume":"147","author":"Lepor","year":"1992","journal-title":"J Urol"},{"issue":"2 Pt 1","key":"10.1016\/j.ucl.2025.07.007_bib7","first-page":"530","article-title":"AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations","volume":"170","year":"2003","journal-title":"J Urol"},{"issue":"20","key":"10.1016\/j.ucl.2025.07.007_bib8","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa061254","article-title":"Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"355","author":"Scheller","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.007_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5489\/cuaj.6323","article-title":"A drug-coated balloon treatment for urethral stricture disease: interim results from the ROBUST I study","volume":"14","author":"Virasoro","year":"2020","journal-title":"Can Urol Assoc J"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.007_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/bco2.312","article-title":"Optilume drug-coated balloon for anterior urethral stricture: 2-year results of the ROBUST III trial","volume":"5","author":"VanDyke","year":"2023","journal-title":"BJUI Compass"},{"key":"10.1016\/j.ucl.2025.07.007_bib11","unstructured":"U.S. Food and Drug Administration. Premarket Approval Application P210020: Optilume BPH Drug Coated Balloon Catheter System. 2021."},{"issue":"5","key":"10.1016\/j.ucl.2025.07.007_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/end.2017.0935","article-title":"Evaluation of the distribution of paclitaxel after application of a paclitaxel-coated balloon in the rabbit urethra","volume":"32","author":"Barbalias","year":"2018","journal-title":"J Endourol"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.007_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41391-021-00362-z","article-title":"One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia","volume":"24","author":"Kaplan","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.007_bib15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/JU.0000000000003568","article-title":"The PINNACLE study: a double-blind, randomized, sham-controlled study evaluating the Optilume BPH catheter system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"210","author":"Kaplan","year":"2023","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.007_bib16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41391-024-00833-z","article-title":"Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study)","volume":"27","author":"Kaplan","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.007_bib17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jsxmed\/qdae206","article-title":"Preservation of sexual function with Optilume-a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"22","author":"Copelan","year":"2025","journal-title":"J Sex Med"},{"key":"10.1016\/j.ucl.2025.07.007_bib18","unstructured":"Laborie Medical Technologies. Optilume BPH procedural protocol. 2022."},{"issue":"3","key":"10.1016\/j.ucl.2025.07.007_bib19","first-page":"11568","article-title":"How i do it: Optilume BPH catheter system","volume":"30","author":"Elterman","year":"2023","journal-title":"Can J Urol"},{"key":"10.1016\/j.ucl.2025.07.007_bib20","unstructured":"Laborie Medical Technologies. Optilume BPH technical guide. 2022."},{"issue":"1","key":"10.1016\/j.ucl.2025.07.007_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ucl.2021.07.007","article-title":"New technologies for treatment of benign prostatic hyperplasia","volume":"49","author":"Elterman","year":"2022","journal-title":"Urol Clin North Am"},{"issue":"25","key":"10.1016\/j.ucl.2025.07.007_bib22","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.007_bib23","first-page":"8802","article-title":"Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study","volume":"24","author":"Roehrborn","year":"2017","journal-title":"Can J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.007_bib24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/JU.0000000000001778","article-title":"Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"206","author":"McVary","year":"2021","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2025.07.007_bib25","first-page":"1069","article-title":"BPH6 randomized controlled study of prostatic urethral lift compared to transurethral resection of the prostate: three-year results","volume":"207","author":"Roehrborn","year":"2022","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.007_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266824","article-title":"A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia","volume":"17","author":"Chughtai","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ucl.2025.07.007_bib27","unstructured":"Laborie Medical Technologies. Optilume BPH Health Economics and Outcomes Research (HEOR) data report. 2023."},{"issue":"1","key":"10.1016\/j.ucl.2025.07.007_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11934-024-01235-3","article-title":"Recent advancements in prostate catheters and stents for management of benign prostatic hyperplasia","volume":"26","author":"Lama","year":"2024","journal-title":"Curr Urol Rep"},{"issue":"10","key":"10.1016\/j.ucl.2025.07.007_bib29","first-page":"2077","article-title":"Treatment algorithm for management of benign prostatic obstruction: an overview of current techniques","volume":"13","author":"Hughes","year":"2023","journal-title":"Life (Basel)"},{"issue":"5","key":"10.1016\/j.ucl.2025.07.007_bib30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.mcna.2024.03.009","article-title":"Advances in outpatient therapies and treatment of benign prostatic hyperplasia: a comprehensive review for men's health","volume":"108","author":"Helman","year":"2024","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.ucl.2025.07.007_bib31","unstructured":"ClinicalTrials.gov. Currently registered clinical trials for Optilume in BPH. Accessed February 15, 2025."},{"key":"10.1016\/j.ucl.2025.07.007_bib32","unstructured":"U.S. Patent and Trademark Office. Patent Applications 17\/658,921 and 17\/843,532. Laborie Medical Technologies. 2022-2023."},{"issue":"8","key":"10.1016\/j.ucl.2025.07.007_bib33","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s00345-023-04473-1","article-title":"Durable benefit after treatment of obstructive benign prostatic hyperplasia with a novel drug-device combination product: 2-year outcomes from the EVEREST-I study","volume":"41","author":"Pichardo","year":"2023","journal-title":"World J Urol"},{"issue":"11","key":"10.1016\/j.ucl.2025.07.007_bib34","doi-asserted-by":"crossref","first-page":"E319","DOI":"10.5489\/cuaj.8737","article-title":"Long-term outcomes after treatment with Optilume BPH Four-year results from the EVEREST study","volume":"18","author":"Kaplan","year":"2024","journal-title":"Can Urol Assoc J"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009401432500062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009401432500062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T14:28:49Z","timestamp":1763044129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009401432500062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S009401432500062X"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2025.07.007","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Balloons in Benign Prostatic Hyperplasia","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2025.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}